According to AlphaMoat, in 2026-08 Clairity (clairity.com) received 5,153 monthly visits (+0.6% MoM) — ranked #12,124 of 17,407 AI websites with traffic data, and #1,996 of 3,173 in Industry Services; its largest market is United States (81.2% of visits).
What is Clairity
Clairity Breast is the first FDA-authorized AI platform that uses existing screening mammography images alone to predict a woman's risk of breast cancer over the next five years, aiming to shift screening from reactive diagnosis to proactive prevention.
- 01Based on deep learning and radiological-image analysis, it identifies subtle patterns invisible to the naked eye
- 02helps clinicians develop personalized care plans for each patient, emphasizing risk detection, interpretable results, and population universality
- 03continuously tracks risk by combining family history, lifestyle, and health-change information
- 04provides risk-assessment services for healthcare providers and patients
It offers risk-assessment products to medical institutions and clinics; the website page does not list explicit product price figures and requires contacting the team for deployment information; classified as a healthcare-industry service by breast-risk assessment.
12-Month Traffic Trend
Visits by Country · Top 5
Popular in Industry Services
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.